ArticlePoultry science2026
Galangin ameliorates Salmonella Pullorum-induced enteritis in Danzhou chicks through gut microbiota-derived indole-3-lactic acid-mediated AHR activation.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic restrictions in poultry production necessitate natural alternatives against Salmonella Pullorum, a pathogen causing severe enteritis and high chick mortality. We show that the dietary flavonoid galangin alleviates S. Pullorum-induced intestinal injury not via direct antimicrobial action, but by modulating gut microbiota to enrich tryptophan-derived indole-3-lactic acid (ILA). Galangin restored growth, preserved barrier integrity, reduced liver bacterial translocation, and suppressed inflammation in infected chicks. Fecal microbiota transplantation from galangin-treated donors recapitulated these benefits, confirming microbiota dependence. ILA activated the aryl hydrocarbon receptor (AHR), concurrently inhibiting NF-κB and HIF-1α pathways-key drivers of Salmonella-exploited inflammation and metabolic reprogramming-thereby enhancing mucosal defense and limiting intracellular bacterial survival. Pharmacological AHR blockade or NF-κB/HIF-1α activation abolished galangin's effects. Collectively, these findings establish that galangin acts as a prebiotic-like agent via the ILA-AHR axis, providing a mechanism-based strategy for antibiotic reduction in sustainable poultry production.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.